| |
| |
|
| Insider
Information: |
Laumas Sandeep |
| Relationship: |
10% Owner |
| City: |
Branford |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
109,238 |
|
|
Indirect Shares
|
1,451,358 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$1 |
|
|
| Total
Shares |
1,560,596 |
|
|
| Total
Value |
$1 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
9 Meters Biopharma Inc |
NMTR |
Director |
2020-06-30 |
60,400 |
2020-06-30 |
758,373 |
Premium* |
|
|
Unicycive Therapeutics, Inc. |
UNCY |
Director |
2021-07-12 |
48,838 |
2021-07-12 |
56,977 |
Premium* |
|
|
Tharimmune |
THAR |
10% Owner |
|
0 |
2022-01-11 |
636,008 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| THAR |
Tharimmune |
10% Owner |
– – • |
2022-01-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
636,008 |
|
- |
|
| UNCY |
Unicycive Therapeutics, I... |
Director |
– • – |
2021-07-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
56,977 |
|
- |
|
| UNCY |
Unicycive Therapeutics, I... |
Director |
– • – |
2021-07-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
48,838 |
|
- |
|
| NMTR |
9 Meters Biopharma Inc |
Director |
– • – |
2020-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
42,400 |
60,400 |
0 |
- |
|
| NMTR |
9 Meters Biopharma Inc |
CEO, Executive Chairman |
• • – |
2019-06-28 |
4 |
B |
$1.15 |
$4,600 |
D/D |
4,000 |
18,000 |
2.73 |
- |
|
| NMTR |
9 Meters Biopharma Inc |
CEO, Executive Chairman |
• • – |
2019-06-13 |
4 |
B |
$1.21 |
$1,216 |
D/D |
1,000 |
14,000 |
2.73 |
- |
|
| NMTR |
9 Meters Biopharma Inc |
CEO, Executive Chairman |
• • – |
2019-05-22 |
4 |
B |
$1.38 |
$6,900 |
D/D |
5,000 |
13,000 |
2.81 |
- |
|
| NMTR |
9 Meters Biopharma Inc |
Executive Chairman |
• • – |
2018-11-30 |
4 |
B |
$2.62 |
$7,890 |
D/D |
3,000 |
8,000 |
2.81 |
- |
|
| NMTR |
9 Meters Biopharma Inc |
Executive Chairman |
• • – |
2018-11-29 |
4 |
B |
$2.55 |
$7,670 |
D/D |
3,000 |
5,000 |
2.81 |
- |
|
| NMTR |
9 Meters Biopharma Inc |
Executive Chairman |
• • – |
2018-09-07 |
4 |
B |
$6.10 |
$3,050 |
D/D |
500 |
2,000 |
2.73 |
- |
|
| NMTR |
9 Meters Biopharma Inc |
Executive Chairman |
• • – |
2018-08-30 |
4 |
B |
$5.24 |
$2,620 |
D/D |
500 |
750 |
2.73 |
- |
|
| NMTR |
9 Meters Biopharma Inc |
Executive Chairman |
• • – |
2018-08-28 |
4/A |
B |
$4.90 |
$1,225 |
D/D |
250 |
250 |
2.73 |
- |
|
| NMTR |
9 Meters Biopharma Inc |
Executive Chairman |
• • – |
2018-08-28 |
4 |
B |
$4.88 |
$3,759 |
D/D |
750 |
1,000 |
2.73 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
